Stay updated on Switching to Cabotegravir and Rilpivirine: Clinical Trial
Sign up to get notified when there's something new on the Switching to Cabotegravir and Rilpivirine: Clinical Trial page.

Latest updates to the Switching to Cabotegravir and Rilpivirine: Clinical Trial page
- Check6 days agoChange DetectedAdded Revision: v3.4.3 and removed Revision: v3.4.2 from the page.SummaryDifference0.0%

- Check13 days agoNo Change Detected
- Check20 days agoChange DetectedNo additions or deletions were detected on the page; the content appears unchanged.SummaryDifference0.0%

- Check34 days agoChange DetectedRevision: v3.4.2 was added and a funding-status notice along with Revision: v3.4.1 were removed. These changes are cosmetic and do not affect study details or user actions on the page.SummaryDifference0.2%

- Check41 days agoChange DetectedA Notice about a lapse in government funding and NIH Clinical Center status was added, with links to cc.nih.gov and opm.gov for updates. The site revision tag was updated from v3.4.0 to v3.4.1.SummaryDifference0.2%

- Check48 days agoChange DetectedPage UI updates add Show glossary, Last Update Submitted that Met QC Criteria, Last Update Posted, No FEAR Act Data, and Revision: v3.4.0, and remove Last Update Submitted that met QC Criteria, Last Update Posted (Estimated), No FEAR Act data, and Revision: v3.3.4. To avoid being alerted by small changes, set an alert condition by clicking below.SummaryDifference0.1%

- Check62 days agoChange DetectedRevision updated from v3.3.3 to v3.3.4; no visible changes to the study details or page functionality. To avoid being alerted by small changes, set an alert condition by clicking below.SummaryDifference0.0%

Stay in the know with updates to Switching to Cabotegravir and Rilpivirine: Clinical Trial
Enter your email address, and we'll notify you when there's something new on the Switching to Cabotegravir and Rilpivirine: Clinical Trial page.